Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (20)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Mechanical stress confers nuclear and functional changes in derived leukemia cells from persistent confined migration

    Cellular and Molecular Life Sciences, Vol. 80, Núm. 11

  3. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  4. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver

    Metabolites, Vol. 12, Núm. 2

  2. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status

    Liver International, Vol. 41, Núm. 11, pp. 2646-2658

  2. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

  3. Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)

    Biomedicines, Vol. 9, Núm. 10

2020

  1. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

2019

  1. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study

    BMC Ophthalmology

2016

  1. Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain

    Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152

2011

  1. Validation of IRF5 as multiple sclerosis risk gene: Putative role in interferon beta therapy and human herpes virus-6 infection

    Genes and Immunity, Vol. 12, Núm. 1, pp. 40-45

2010

  1. Esplenomegalia familiar como manifestación clínica del síndrome linfoprolifetativo autoinmune

    Anales de Pediatria, Vol. 72, Núm. 4, pp. 278-281

2005

  1. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes

    Journal of Leukocyte Biology, Vol. 77, Núm. 5, pp. 661-668